Anton Gueth

This profile gathers the share dealings of Anton Gueth across 3 companies, led by Antares Pharma, Inc., Navidea Biopharmaceuticals, Inc. and Spectrum Pharmaceuticals Inc. We count 62 filings; the first trade dates from 15 May 2009 and the latest from 24 May 2022.

Both buying and selling appear: 4 purchases worth €48k, against 6 sales worth €887k. Taken together, the sales exceed the purchases by €839k. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Besides market trades, the filings include 27 share grants and 22 option exercises.

Half of the purchases are above €7,932 and half below.

The record was last updated on 26 May 2022 with a transaction (€9,389) in Antares Pharma, Inc. The last purchase on record was published on 21 March 2016, which is 3,869 days ago. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. For comparison, the SEC allows two business days to file a Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.